Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs & Pharmaceuticals Ltd (WELCURE) is a micro-cap Healthcare company valued at ₹23 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Welcure Drugs & Pharmaceuticals Ltd last traded at ₹0.2, unchanged on the day.

Recent developments

On 2026-03-31, the company reported a net loss of ₹5 crore for the latest fiscal year, marking a swing from a net profit of ₹2 crore in the prior year. In the latest quarter, the company recorded a net loss of ₹50 crore, a sharp decline from a net profit of ₹3 crore in the same quarter a year earlier.

Financial performance

The company's business has grown significantly, with annual revenue rising 1389.0% to ₹366 crore. However, net profit swung from a profit of ₹2 crore to a loss of ₹5 crore, and the net profit margin fell 10.3 percentage points to -1.5%. The latest quarter saw revenue drop 100.0% to ₹0 crore, and net profit swung from a profit of ₹3 crore to a loss of ₹50 crore.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.28 times book value.

Things to watch

The company reported a net loss of ₹5 crore in the latest fiscal year, a significant swing from a net profit of ₹2 crore in the prior year. The latest quarter saw a net loss of ₹50 crore, a sharp decline from a net profit of ₹3 crore in the same quarter a year earlier. The stock is 68.8% below its 52-week high.

Where it stands

The company reported a net loss of ₹5 crore in the latest fiscal year, with the latest quarter showing a net loss of ₹50 crore. The stock is 68.8% below its 52-week high, and the net profit margin has fallen to -1.5%.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.